Improved Solubilization of Recombinant Human Growth Hormone Inclusion Body Produced in<i>Escherichia coli</i>

DOI Web Site Web Site 参考文献38件
  • SONODA Hiroyuki
    Medical Technology Research Center, Research Division, JCR Pharmaceuticals Co., Ltd.
  • SUGIMURA Atsushi
    Medical Technology Research Center, Research Division, JCR Pharmaceuticals Co., Ltd.

書誌事項

タイトル別名
  • Improved Solubilization of Recombinant Human Growth Hormone Inclusion Body Produced in Escherichia coli

この論文をさがす

説明

Recombinant human growth hormone (r-hGH) overexpressed in Escherichia coli forms inactive and insoluble aggregates as inclusion bodies in the cytoplasm. The efficient solubilization of inclusion bodies is critical for cost-effective production. Contrary to a previous report, in our production system, the solubilization method by alkaline treatment including 2 M urea was ineffective. Hence various buffers containing different concentrations of urea or guanidine hydrochloride (GnHCl) at neutral and alkaline pH were attempted. Efficient solubilization (about 90%) was observed in 100 mM Tris buffer, pH 8.0, with more than 4 M GnHCl, and at pH 12.5 with more than 2 M GnHCl, but not with about 8 M of urea. The r-hGH solubilized at pH 12.5 containing 2 M GnHCl was refolded by simple dilution and purified by DEAE Sepharose anion-exchange chromatography. The biological activity of the resulting r-hGH was comparable with commercially available r-hGH in in vitro cell proliferation assay using the hGH-dependent cell line.

収録刊行物

参考文献 (38)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ